DCF — MEDICAL CENTER ENTERPRISE
Enterprise Value: $-2.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.3M
Enterprise Value
$-2.3M
PV of Cash Flows
$-0.0M
PV of Terminal Value
$-0.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $60.9M | $1.2M | 2.0% | $-1.3M | $-1.2M |
| Year 2 | $62.7M | $1.9M | 3.0% | $-0.8M | $-0.7M |
| Year 3 | $64.6M | $2.6M | 4.0% | $-0.4M | $-0.3M |
| Year 4 | $66.5M | $3.0M | 5.0% | $-0.1M | $-0.1M |
| Year 5 | $68.5M | $3.3M | 5.0% | $-0.0M | $-0.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$59.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.015518237980785006
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5